新闻中心

News Center

The company participated in the 70th (Guangzhou) National Pharmaceutical Fair

Release Time

2022-06-22 11:10

From December 5th to 7th, 2013, the company participated in the 70th National Pharmaceutical Fair held in Guangzhou. At this drug fair, our company exhibited Yulin® Yinpu Jiedu Tablets, Foncoo® Xinnaoxin Pills, Duodi® Doxycycline Hydrochloride Dispersible Tablets, Yulin® Sanqi Shangyao Capsules, which have been sold by the company for many years. In addition to more than 10 key products, it also exhibited a new blockbuster product in the field of psychiatry, Olanzhi® Olanzapine Tablets, which was introduced in November this year, and received thousands of dealers from all over the country. The company's booth has an endless stream of customers who inquired about Olanzhi® olanzapine tablets. Customers from various provinces expressed their strong interest in Olanzhi® and firmly believed that there will be a good market prospect! Through this drug fair, the company's products and corporate image have been publicized, especially the new product Olanzhi® Olanzapine Tablets, and valuable market information and product trends have also been collected to reserve more for provinces across the country. customer resources, and achieved very satisfactory results!

 

 

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称